Two packages, both developed to aid patients with metastatic breast cancer, tied for the Compliance Package of the Year award in the Healthcare Compliance Packaging Council (HCPC)’s annual competition.
Novartis Kisqali Dosepak and Lilly Verzenio Dosepak earned HCPC’s top honors as the most innovative pharmaceutical packages designed to improve patient adherence for the preceding market year, 2017.




















